echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Endometrial cancer: predictive lymph node metastasis model

    Endometrial cancer: predictive lymph node metastasis model

    • Last Update: 2021-01-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A study by Berg and others at the University of Berg in Norway demonstrated that data-driven predictive models that add protein markers to clinical information about endometrial cancer (EEC) have significant potential for improving diagnosis in patients with preoperative lymph node metastasis (LNM).
    (Br J Cancer. 2020 doi:10.1038/s41416-020-0745-6.) In the EEC, current clinical algorithms are unable to accurately predict patients accompanying LNM, which leads to undertreated and overtreated patients.
    the study aims to develop a model that combines protein data with clinical information to identify patients who need more aggressive surgery, including lymph node cleaning.
    protein expression spectrum was produced in 399 patients using an inverse protein array.
    used training sets to build three broad linear models, including protein and clinical information (model 1), magnetic resonance imaging information (model 2) and protein-only information (model 3), and tested it in a separate validation set.
    the test using gene expression data from the tumor.
    predicted LNM with a curved area of 0.72-0.89 and cell cycle protein D1;
    high levels of fiber-linked proteins and cell cycle protein D1 were associated with poor survival rates (P-0.018) and were associated with tumor immersion markers.
    of FN1 and CCND1 messenger RNA was associated with cancer attacks and mesothyst esolyses.
    Zhang Shi former source: Zhang Shi former public number copyright notice: All the text, pictures and audio and video materials marked "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mace Medical, without authorization, no media, website or individual may reproduce, authorized to reproduce must indicate "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.